The Impact of Coexistence of Smoking and Diabetes on the Coronary Artery Severity and Outcomes following Percutaneous Coronary Intervention: Results from the 1ST Jordanian PCI Registry
Table 1
Baseline features of the diabetic-smokers compared with the other 3 groups in a cohort of 2426 patients.
Clinical variable
Total number
Diabetic-smokers
Diabetic-nonsmokers
Nondiabetic-smokers
Nondiabetic-nonsmokers
value
Number (%)
2426
467 (19.2%)
833 (34.3%)
588 (24.2%)
538 (22.2%)
<0.0001
Females (, %)
500
32 (6.9%)
316 (37.9%)
31 (5.3%)
121 (22.5%)
<0.0001
Hypertension (, %)
1511
299 (64.0%)
638 (76.6%)
247 (42.0%)
327 (60.8%)
<0.0001
≤45 years of age
308
83 (17.8%)
34 (4.1%)
158 (26.9%)
33 (6.1%)
<0.0001
Dyslipidemia (, %)
1184
247 (52.9%)
494 (59.3%)
221 (37.6%)
222 (41.3%)
<0.0001
kg/m2
1877
430 (92%)
661 (79.4%)
422 (71.8%)
364 (67.7%)
0.003
Chronic renal disease
69
10 (2.1%)
39 (4.7%)
6 (1.0%)
14 (2.6%)
0.001
Family history of premature CVD
956
221 (47.3%)
301 (36.1%)
241 (41%)
193 (35.9%)
<0.0001
Past history of CVD
954
180 (38.5%)
385 (46.2%)
178 (30.3%)
211 (39.2%%)
0.0001
Past history of coronary revascularization (PCI or CABG)
673
123/PCI 16/ 29.7%
230/PCI 30/ 31.2%
106/PCI 14/ 20.4%
130/PCI 24/ 28.6%
Pci:0.0001 CABG:0.528
Low LVEF (≤45%)
302
62 (13.3%)
119 (14.3%)
64 (10.9%)
57 (10.6%)
0.123
BMI: body mass index; CABG: coronary artery bypass graft; CVD: cardiovascular disease; LVEF: left ventricular ejection fraction; PCI: percutaneous coronary intervention; SD: standard deviation (, significant).
